2,3-Quinoxalinedione,1,4-dihydro-,monooxime(9CI)结构式
|
常用名 | 2,3-Quinoxalinedione,1,4-dihydro-,monooxime(9CI) | 英文名 | 2,3-Quinoxalinedione,1,4-dihydro-,monooxime(9CI) |
|---|---|---|---|---|
| CAS号 | 177944-77-3 | 分子量 | 177.16000 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C8H7N3O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 2-(hydroxymethylidene)-1,4-dihydropyrido[2,3-b]pyrazin-3-one |
|---|
| 分子式 | C8H7N3O2 |
|---|---|
| 分子量 | 177.16000 |
| 精确质量 | 177.05400 |
| PSA | 82.03000 |
| LogP | 0.24060 |
|
~41%
2,3-Quinoxaline... 177944-77-3 |
| 文献：State of Oregon, Acting by and through the Oregon State Board of Higher Education, Acting for and on Behalf of the Oregon Health Sciences University and the University of Oregon; Acea Pharmaceuticals, Inc.; The Regents of the University of California Patent: US5597922 A1, 1997 ; US 5597922 A |
|
~0%
2,3-Quinoxaline... 177944-77-3 |
| 文献：State of Oregon, Acting by and through the Oregon State Board of Higher Education, Acting for and on Behalf of the Oregon Health Sciences University and the University of Oregon; Acea Pharmaceuticals, Inc.; The Regents of the University of California Patent: US5597922 A1, 1997 ; US 5597922 A |
